# Eyal David

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eyal-david/

## Facts

| Field | Value |
| --- | --- |
| Citations | 35,407 |
| Field | Diabetes and associated disorders |
| h-index | 64 |
| i10-index | 89 |
| Last Known Institution | Weizmann Institute of Science |
| OpenAlex ID | https://openalex.org/A5030630152 |
| ORCID iD | https://orcid.org/0000-0002-9020-2364 |
| Works | 302 |

## Researcher papers

- [Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation](https://scholariq.org/papers/systemic-human-ilc-precursors-provide-a-substrate-for-tissue-ilc-differentiation/)
- [Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome](https://scholariq.org/papers/cancer-associated-fibroblast-compositions-change-with-breast-cancer-progression/)
- [LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma](https://scholariq.org/papers/lgr5-expressing-skin-fibroblasts-define-a-major-cellular-hub-perturbed-in/)

## Researcher topics

- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)
- [Inflammation biomarkers and pathways](https://scholariq.org/topics/inflammation-biomarkers-and-pathways/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [Weizmann Institute of Science](https://scholariq.org/institutions/weizmann-institute-of-science/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.